- Home
- SSP vs LENZ Comparison
SSP vs LENZ Comparison
Compare SSP & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSP | LENZ |
|---|---|---|
| Founded | 1878 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.6M | 198.8M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SSP | LENZ |
|---|---|---|
| Price | $2.75 | $5.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.95 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 574.7K | 556.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,150,585,000.00 | $19,088,000.00 |
| Revenue This Year | $8.34 | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.04 | $6.29 |
| 52 Week High | $5.39 | $50.19 |
Technical Indicators
Market Signals| Indicator | SSP | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 29.81 | 29.43 |
| Support Level | $2.73 | N/A |
| Resistance Level | $3.01 | $10.42 |
| Average True Range (ATR) | 0.21 | 0.43 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 21.37 | 3.26 |
Price Performance
Historical ComparisonAbout SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.